Contents
103 CAR T-cell therapy: managing side effects
106 Perspectives for treating cancer-associated thrombosis
108
Implications of licensed standardised chemotherapy
doses and their potential impact
Hope bulletin
8 The challenge of integrated care in Europe
12 Hospitals in Europe: Healthcare data
24 EU hospitals and healthcare services
Neurology
cardiovascular
112 2018 NICE guidelines for Parkinson’s disease
117 Managing refractory seizures in tuberous
sclerosis complex
121 Mechanical thrombectomy in acute ischaemic stroke
126 The challenge of integrated care in Europe
131 Managing spinal muscular atrophy
41 PCSK9 inhibitors: hope or hype?
47 The leadless pacemaker: a new era in cardiac pacing
53 Cardiac biomarkers: the power of innovation
55 Preventing and treating VTE in patients with renal
insufficiency
60 The importance of vascular access device selection:
a case study
pathology
137 Predictive bioanalysis in NSCLC
141 Circulating tumour cells as liquid biopsy:
technical aspects
146 The new kid on the block
152 Point of care testing in virology
Emergency and critical care
65 Universal, successful and without borders
66 suPAR in the ED: Should they stay or should they
go now?
68 Sedation in neurocritical care
74 Recent developments in surgical sepsis
80 Targeted temperature management for cardiac arrest
84 Situation awareness during crisis in the OR
radiology and imaging
157 Value-based radiology
161 Managing the risks of contrast agents in imaging
164 New evidence for digital mammography plus
tomosynthesis
166 Artificial intelligence and radiology
169 Ensuring safety in nuclear medicine
172 Radiological treatments for uterine fibroids
haematology and oncology
89 Targeting optimal care, together
91 Anti-GD2 mAbs for the treatment of high-risk
neuroblastoma
97 Evolving protection in haemophilia
101 Oral anticoagulants and cancer-associated thrombosis
rheumatology AND MUsculoskeletal
177 Challenges in the management of psoriatic arthritis
180 JAK inhibitors in the treatment of rheumatoid arthritis
183 International updates and 2017 criteria of the
Ehlers-Danlos syndromes
186 Treating giant cell arteritis
190 Optimising management of systemic lupus
erythematosus
195 Novel treatments in the management of myositis
Theatre and surgery
201 Severe adverse events in the operating theatre
204 Recent developments in surgical sepsis
209 Stress immunity in surgeons
212 Optimal analgesia for major open surgery
215 Monitoring during anaesthesia and recovery
910
4
HHE 2018 | hospitalhealthcare.com